Key Takeaways
- Accenture (ACN) shares declined 4% to reach a 52-week low near $182 following fiscal 2026 revenue projections ($71.8B–$73.2B) that fell short of analyst estimates around $73.9B.
- The company exceeded Q2 expectations with earnings per share of $2.93 compared to analyst forecasts of $2.84, while revenue reached $18.04B, representing 7.8% year-over-year growth.
- UBS analyst Kevin McVeigh suggests investors are overlooking Accenture’s artificial intelligence expansion, which has generated 200% compound annual growth in AI-linked revenue since fiscal 2023.
- The company increased its FY2026 acquisition budget to $5B from an earlier $3B target, having already committed $1.6B toward deals including Keepler Data Tech, NeuraFlash, Halfspace, and Decho.
- Microsoft (MSFT), another key player in AI discussions, has declined 21% year to date while trading at approximately 22x trailing earnings—its most attractive valuation in nearly ten years.
Shares of Accenture (ACN) began Friday trading at $186.04 following a 4% decline. The consulting giant reached a fresh 52-week low, with its annual trading range spanning from $182.38 to $325.71. The downturn stems from investor reaction to forward-looking projections that fell below market expectations.
The company’s leadership team projected fiscal year 2026 revenue between $71.8 billion and $73.2 billion. Wall Street analysts had anticipated approximately $73.9 billion. This variance pushed shares to their lowest point in twelve months, despite strong performance in the most recent quarter.
Accenture’s latest quarterly results delivered earnings per share of $2.93, surpassing the $2.84 consensus estimate by $0.09. Revenue totaled $18.04 billion, representing 7.8% growth compared to the prior-year period and exceeding the $17.80 billion forecast. The company posted a return on equity of 26.33%.
Accenture declared a quarterly dividend of $1.63 per share, scheduled for distribution on May 15 to shareholders registered by April 9. Based on current trading levels, this represents a 3.5% annualized dividend yield.
UBS Points to Mispriced AI Growth Trajectory
Kevin McVeigh, an analyst at UBS, released research highlighting what he perceives as market misjudgment of Accenture’s value proposition. His analysis centered on the company’s recent purchase of Keepler Data Tech, a Spanish firm bringing approximately 240 experts in data science, machine learning, and cloud infrastructure.
McVeigh contends that Accenture’s artificial intelligence initiatives demonstrate greater coordination and acceleration than current market pricing reflects. Following the launch of generative AI programs in fiscal 2023, the company has expanded AI-related revenue to approximately $2.7 billion by fiscal 2025—representing a compound annual growth rate near 200%. This trajectory exceeds the company’s initial cloud business expansion, which achieved roughly 132% growth during comparable early stages.
The consulting firm elevated its fiscal 2026 acquisition spending target from $3 billion to $5 billion. Approximately $1.6 billion has been allocated across transactions including NeuraFlash, Halfspace, and Decho. McVeigh interprets this as a strategic pivot toward higher-margin, technology-centric operations compared to conventional labor-dependent consulting services.
Accenture currently employs over 85,000 professionals focused on artificial intelligence. Bookings related to AI and data collaborations are projected to more than double during fiscal 2026.
Major Investors Adjust Holdings
Institutional shareholders have actively repositioned their ACN stakes throughout recent quarters. Capital International Investors expanded its holdings by 41.1% during Q3, accumulating over 17 million shares worth approximately $4.2 billion. Massachusetts Financial Services increased its position by 12.8%, now controlling about 10.1 million shares.
DDD Partners LLC established a fresh position during Q4, purchasing 9,090 shares valued at roughly $2.44 million.
Institutional and hedge fund entities currently control 75.14% of outstanding shares.
Wall Street analyst sentiment leans cautiously optimistic overall. Eighteen analysts assign Buy ratings to the stock, while ten recommend Hold positions. The average price target sits at $274.88, substantially above current trading levels.
The company’s 50-day moving average registers at $210.98, with the 200-day average at $241.88. Friday’s opening price positioned ACN below both technical indicators.
